Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00362479 · ClinicalTrials.gov registry record · Phase 3
Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive
A Phase 3 study, sponsored by Duramed Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,347
- Enrollment target
NCT00362479: Completed Phase 3 study, sponsored by Duramed Research.
NCT00362479 is a Phase 3 study that has completed, run by Duramed Research. The registered enrollment target is 1,347 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (74% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00362479, a Phase 3 study, has completed, sponsored by Duramed Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,347 participants
- Enrollment target
Study Summary
This is an open-label, single treatment study. All subjects will receive 6 months of oral contraceptive therapy with DR-1021. Study participants will receive physical and gynecological exams, including Pap smear. During the study, all participants will be required to complete a diary.
Interventions
- DRUG DR-1021
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,347 participants |
| Start Date | 2006-08 |
| Est. Completion | 2007-07 |
| Phase | Phase 3 |
What the finished NCT00362479 record still lists
NCT00362479 is an interventional study that assigns participants to a tested intervention. Its 1,347 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (74% higher).
The record links to 0 conditions, and to 1 intervention - of which DR-1021 is the first listed.
NCT00362479 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00362479 about?
NCT00362479 is a clinical study titled "Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive". This is an open-label, single treatment study. All subjects will receive 6 months of oral contraceptive therapy with DR-1021. Study participants will receive physical and gynecological exams, including Pap smear. During the study, all participants will be required to complete a diary.
What is the current status of trial NCT00362479?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,347 participants. The study started on 2006-08. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00362479?
The interventions under investigation include: DR-1021 (DRUG).
Who is sponsoring clinical trial NCT00362479?
This trial is sponsored by Duramed Research, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00362479's enrollment target sits among peer trials
1,347 182nd of 2000 higher than 1,819 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06318169 · 1,350 participants · Phase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- NCT06605404 · 1,350 participants
Pan-tumor MRD Study
- NCT06806163 · 1,350 participants · NA
Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
- NCT06731608 · 1,344 participants · NA
OsteoPorotic fracTure preventION System (OPTIONS) Research Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia